Next, knowledge of CCR7+ DC ontogeny remains incomplete6,8, particularly the relative contribution of cDC subsets or monocytes to heterogeneous tumour-residing CCR7+ DC states, which may influence their ability to support CD8+ versus CD4+ T cell responses. The gene discussed is CD8A; the disease is neoplasm.